WST - WEST PHARMACEUTICAL SERVICES INC

QQQ $ 587.58 $ 0.25 (0.04 %)

DIA $ 458.44 $ -1.03 (-0.22 %)

SPY $ 654.78 $ -0.23 (-0.04 %)

TLT $ 89.53 $ -0.13 (-0.14 %)

GLD $ 374.46 $ 0.53 (0.14 %)

Previous Close

$ 257.77

Open

$ 260.95

Bid

$ 261.07 x 81

Ask

$ 261.61 x 29

Day's Range

$ 260.47 - $ 262.00

52 Week Range

$ 186.94 - $ 347.77

Volume

1,315,133

Average Volume

Market Cap

18.54B

Beta (5Y Monthly)

$ 1.07

PE Ratio (TTM)

$ 37.72

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

looking-into-west-pharmaceutical-services-incs-recent-short-interest

Looking Into West Pharmaceutical Services ...
11/20/2025 16:00:30

TD Cowen Initiates Coverage On West Pharma...
10/29/2025 13:00:38

TD Cowen analyst Brendan Smith initiates coverage on West Pharmaceutical Servs (NYSE:WST) with a Buy rating and announces Pr...

Barclays Maintains Equal-Weight on West Ph...
10/27/2025 16:25:26

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target...

1. West Pharmaceutical Unveils New Prefill...
10/27/2025 10:10:20

West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, tod...

Demystifying West Pharmaceutical Servs: In...
10/24/2025 18:01:34

UBS Maintains Buy on West Pharmaceutical S...
10/24/2025 15:05:44

UBS analyst John Sourbeer maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $320 to...

Keybanc Maintains Overweight on West Pharm...
10/24/2025 12:33:41

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target fro...

Evercore ISI Group Maintains Outperform on...
10/23/2025 17:54:02

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the ...

oil-stocks-rally-on-trumps-russia-sanctions-whats-moving-markets-thursday

Oil Stocks Rally On Trump's Russia Sanctio...
10/23/2025 16:55:59

Energy markets dominated headlines Thursday as a fresh wave of U.S. sanctions targeting Russia's oil giants sparked a sharp...

west-pharma-soars-after-q3-beat-lifts-outlook-on-glp-1-demand

West Pharma Soars After Q3 Beat, Lifts Out...
10/23/2025 16:16:29

West Pharmaceutical posts Q3 earnings of $1.96 per share and raises 2025 guidance, driven by GLP-1 demand and strong HVP compon...

las-vegas-sands-posts-upbeat-q3-results-joins-garrett-motion-lendingclub-dow-hexcel-and-other-big-stocks-moving-higher-on-thursday

Las Vegas Sands Posts Upbeat Q3 Results, J...
10/23/2025 14:34:47

West Pharmaceutical Servs Raises FY2025 Ad...
10/23/2025 10:02:06

West Pharmaceutical Servs (NYSE:WST) raises FY2025 Adj EPS guidance from $6.65-$6.85 to $7.06-$7.11 vs $6.77 analyst estimate. ...

West Pharmaceutical Servs Raises FY2025 GA...
10/23/2025 10:01:29

West Pharmaceutical Servs (NYSE:WST) raises FY2025 GAAP EPS guidance from $6.36-$6.56 to $6.75-$6.80 vs $6.53 analyst estimate..

West Pharmaceutical Servs Q3 Adj. EPS $1.9...
10/23/2025 10:00:55

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $1.96 per share which beat the analyst consensus estimate o...

Earnings Scheduled For October 23, 2025
10/23/2025 08:32:24

West Pharmaceutical Servs's Earnings Outlook
10/22/2025 16:02:08

Barclays Maintains Equal-Weight on West Ph...
10/02/2025 15:08:24

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target...

Deep Dive Into West Pharmaceutical Servs S...
10/02/2025 14:01:02

Looking Into West Pharmaceutical Servs's R...
09/25/2025 18:00:56

West Pharmaceutical Servs's (NYSE: WST) short interest as a percent of float has risen 9.25% since its last report. Accordi...

Rothschild & Co Initiates Coverage On West...
09/15/2025 13:42:34

Rothschild & Co analyst Jamie Clark initiates coverage on West Pharmaceutical Servs (NYSE:WST) with a Buy rating and ann...